{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:49:45Z","timestamp":1792802985277,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Mol Morphol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00795-023-00353-0","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T15:04:16Z","timestamp":1681916656000},"page":"187-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Elevated expression of endocan in the development of cervical squamous neoplasia of the uterus"],"prefix":"10.1007","volume":"56","author":[{"given":"Midori","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Takasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumi","family":"Takasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kyuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazufumi","family":"Magara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1754-252X","authenticated-orcid":false,"given":"Makoto","family":"Osanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"353_CR1","doi-asserted-by":"publisher","first-page":"20458","DOI":"10.1074\/jbc.271.34.20458","volume":"271","author":"P Lassalle","year":"1996","unstructured":"Lassalle P, Molet S, Janin A, Heyden JV, Tavernier J, Fiers W, Devos R, Tonnel AB (1996) ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem 271:20458\u201320464","journal-title":"J Biol Chem"},{"key":"353_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3109\/10520295.2011.577754","volume":"87","author":"SM Zhang","year":"2012","unstructured":"Zhang SM, Zuo L, Zhou Q, Gui SY, Shi R, Wu Q, Wei W, Wang Y (2012) Expression and distribution of endocan in human tissues. Biotech Histochem 87:172\u2013178","journal-title":"Biotech Histochem"},{"key":"353_CR3","first-page":"25","volume":"1765","author":"S Sarrazin","year":"2006","unstructured":"Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V, Landolfi C, Lortat-Jacob H, Bechard D, Lassalle P, Delehedde M (2006) Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta 1765:25\u201337","journal-title":"Biochim Biophys Acta"},{"key":"353_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.anai.2021.03.020","volume":"127","author":"N \u00d6ztop","year":"2021","unstructured":"\u00d6ztop N, \u00d6zer PK, Demir S, Beyaz S, Tiryaki TO, \u00d6zkan G, Aydogan M, Bugra MZZ, \u00c7olakoglu B, B\u00fcy\u00fck\u00f6zt\u00fcrkn S, Nal\u00e7ac\u0131 M, Yavuz AS, Gelincik A (2021) Impaired endothelial function irrespective of systemic inflammation or atherosclerosis in mastocytosis. Ann Allergy Asthma Immunol 127:76\u201382","journal-title":"Ann Allergy Asthma Immunol"},{"key":"353_CR5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1161\/CIRCRESAHA.115.304718","volume":"115","author":"SF Rocha","year":"2014","unstructured":"Rocha SF, Schiller M, Jing D, Li H, Butz S, Vestweber D, Biljes D, Drexler HCA, Nieminen-Kelh\u00e4 M, Vajkoczy P, Adams S, Benedito R, Adams RH (2014) sm1 modulates endothelial tip cell behavior and vascular permeability by enhancing VEGF bioavailability. Circ Res 115:581\u2013590","journal-title":"Circ Res"},{"key":"353_CR6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41419-022-05501-5","volume":"13","author":"J Lu","year":"2022","unstructured":"Lu J, Liu Q, Zhu L, Liu Y, Zhu X, Peng S, Chen M, Li P (2022) Endothelial cell-specific molecule 1 drives cervical cancer progression. Cell Death Dis 13:1043","journal-title":"Cell Death Dis"},{"key":"353_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3892\/br.2015.438","volume":"3","author":"J Yang","year":"2005","unstructured":"Yang J, Yang Q, Yu S, Zhang X (2005) Endocan: a new marker for cancer and a target for cancer therapy. Biomed Rep 3:279\u2013283","journal-title":"Biomed Rep"},{"key":"353_CR8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s10388-020-00796-9","volume":"18","author":"Y Cui","year":"2021","unstructured":"Cui Y, Guo W, Li Y, Shi J, Ma S, Guan F (2021) Pan-cancer analysis identifies ESM1 as a novel oncogene for esophageal cancer. Esophagus 18:326\u2013338","journal-title":"Esophagus"},{"key":"353_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.21873\/invivo.11796","volume":"34","author":"K Kano","year":"2020","unstructured":"Kano K, Sakamaki K, Oue N, Kimura Y, Hashimoto I, Hara K, Maezawa Y, Aoyama T, Fujikawa H, Hiroshima Y, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Cho H, Ito H, Shiozawa M, Yukawa N, Yoshikawa T, Morinaga S, Rino Y, Yasui W, Masuda M, Miyagi Y, Oshima T (2020) ESM-1 gene expression on outcomes in stage II\/III gastric cancer patients who received adjuvant S-1 chemotherapy. Vivo 34:461\u2013467","journal-title":"Vivo"},{"key":"353_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/340140a0","volume":"340","author":"AJ Durston","year":"1989","unstructured":"Durston AJ, Timmermans JP, Hage WJ, Hendriks HF, de Vries NJ, Heideveld M, Nieuwkoop PD (1989) Retinoic acid causes an anteroposterior transformation in the developing central nervous system. Nature 340:140\u2013144","journal-title":"Nature"},{"key":"353_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1146\/annurev.bi.64.070195.001221","volume":"64","author":"A Means","year":"1995","unstructured":"Means A, Gudas LJ (1995) The roles of retinoids in vertebrate development. Annu Rev Biochem 64:210\u2013233","journal-title":"Annu Rev Biochem"},{"key":"353_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/330444a0","volume":"330","author":"M Petkovich","year":"1987","unstructured":"Petkovich M, Brand NJ, Krust A, Chambon P (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330:444\u2013450","journal-title":"Nature"},{"key":"353_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/onc.2009.414","volume":"29","author":"M Osanai","year":"2010","unstructured":"Osanai M, Sawada N, Lee GH (2010) Oncogenic and cell survival properties of the retinoic acid metabolizing enzyme, CYP26A1. Oncogene 29:1135\u20131144","journal-title":"Oncogene"},{"key":"353_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/pin.12532","volume":"67","author":"M Osanai","year":"2017","unstructured":"Osanai M (2017) Cellular retinoic acid bioavailability in various pathologies and its therapeutic implication. Pathol Int 67:281\u2013289","journal-title":"Pathol Int"},{"key":"353_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00795-022-00345-6","volume":"56","author":"M Osanai","year":"2023","unstructured":"Osanai M, Takasawa A, Takasawa K, Kyuno D, Ono Y, Magara K (2023) Retinoic acid metabolism in cancer: potential feasibility of retinoic acid metabolism blocking therapy. Med Mol Morphol 56:1\u201310","journal-title":"Med Mol Morphol"},{"key":"353_CR16","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/bjc.1998.207","volume":"77","author":"Van heusden J, Wouters W, Ramaekers","year":"1998","unstructured":"Van heusden J, Wouters W, Ramaekers FC, Krekels MD, Dillen L, Borgers M, Smets G, (1998) The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells. Br J Cancer 77:1229\u20131235","journal-title":"Br J Cancer"},{"key":"353_CR17","first-page":"629","volume":"9","author":"E Sonneveld","year":"1998","unstructured":"Sonneveld E, van den Brink CE, van der Leede BM, Schulkes RK, Petkovich M, van der Burg B, van der Saag PT (1998) Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells. Cell Growth Diff 9:629\u2013637","journal-title":"Cell Growth Diff"},{"key":"353_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1054\/bjoc.2001.1952","volume":"85","author":"I Iaassen","year":"2001","unstructured":"Iaassen I, Brakenhoff RH, Smeets SJ, Snow GB, Braakhuis BJ (2001) Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells. Br J Cancer 85:630\u2013635","journal-title":"Br J Cancer"},{"key":"353_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/ajh.10099","volume":"70","author":"B Ozpolat","year":"2002","unstructured":"Ozpolat B, Mehta K, Tari AM, Tari AM, Lopez-Berestein G (2002) All-trans-retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia. Am J Hematol 70:39\u201347","journal-title":"Am J Hematol"},{"key":"353_CR20","doi-asserted-by":"publisher","first-page":"7571","DOI":"10.1158\/0008-5472.CAN-06-1067","volume":"66","author":"DN Shelton","year":"2006","unstructured":"Shelton DN, Sandoval IT, Eisinger A, Chidester S, Ratnayake A, Ireland CM, Jones DA (2006) Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development. Cancer Res 66:7571\u20137577","journal-title":"Cancer Res"},{"key":"353_CR21","unstructured":"WHO Classification of Tumours Editorial Board 2020 Female genital tumours. International Agency for Research on Cancer (WHO classification of tumours Lyon series, 5th ed.; vol.4)"},{"key":"353_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl 48:452\u2013458","journal-title":"Bone Marrow Transpl"},{"key":"353_CR23","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1128\/jvi.67.8.4521-4532.1993","volume":"67","author":"SW Straight","year":"1993","unstructured":"Straight SW, Hinkle PM, Jewers RJ, McCance DJ (1993) The E5 oncoprotein of human papilloma virus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J Virol 67:4521\u20134532","journal-title":"J Virol"},{"key":"353_CR24","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1038\/s41598-021-84787-5","volume":"11","author":"A Nagy","year":"2021","unstructured":"Nagy A, Munkacsy G, Gyorffy B (2021) Pancancer survival analysis of cancer hallmark genes. Sci Rep 11:6047","journal-title":"Sci Rep"}],"container-title":["Medical Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-023-00353-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00795-023-00353-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-023-00353-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T16:12:59Z","timestamp":1691683979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00795-023-00353-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1007\/s00795-023-00353-0","relation":{},"ISSN":["1860-1480","1860-1499"],"issn-type":[{"value":"1860-1480","type":"print"},{"value":"1860-1499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"11 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that we have no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study was reviewed and approved by the Institutional Ethics Committee (approval no. 4-1-44) and Institutional Review Board (study no. 312-230) of Sapporo Medical University. The Ethics Committee waived the requirement to obtain written informed consent from the patients for the use of human tissues owing to the retrospective nature of the study. The research was conducted in accordance with the Declaration of Helsinki. The researchers involved in this study had no access to information that could identify individual participants during or after data collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}